Head of Human Resources at 1910 Genetics

Boston, Massachusetts, United States

1910 Genetics Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

  • Strategic, human capital business advisor experience
  • Ability to translate corporate strategy into a human resources strategy
  • Experience participating in the development of company plans and programs
  • Understanding of key business drivers and ability to deliver HR initiatives
  • Experience creating onboarding and orientation programs
  • Knowledge of market trends in pay, benefits, and rewards structures

Responsibilities

  • Work closely with the senior leadership team (SLT) to translate 1910’s corporate strategy into a human resources strategy
  • Function as a strategic, human capital business advisor to the SLT
  • Participate as a strategic partner in the development of 1910’s plans and programs, particularly from the perspective of impact on people
  • Advise on programs to improve attracting, motivating, developing, and retaining talented team members
  • Prepare Company handbook reflecting policies, procedures, working conditions, and behavioral expectations
  • Identify and understand key business drivers and ensure effective HR initiatives and solutions are delivered
  • Create robust onboarding and orientation programs for new hires
  • Monitor and report on market trends in pay, benefits, and rewards structures; develop and enhance compensation & benefits programs

Skills

HR Strategy
Strategic Business Advising
Talent Management
Onboarding Programs
Compensation Planning
Benefits Design
Employee Handbook
Market Trends Analysis

1910 Genetics

AI-driven drug discovery for challenging diseases

About 1910 Genetics

1910 Genetics focuses on improving drug discovery by combining artificial intelligence with biological research. Their technology helps identify and develop treatments for diseases that are hard to treat using traditional methods, specifically targeting "undruggable" parts of the human proteome. The company works with pharmaceutical firms, research institutions, and healthcare providers to create new small molecule drugs and protein therapeutics more efficiently. Unlike many competitors, 1910 Genetics offers a complete platform that covers the entire early drug discovery process, from target identification to treatment design. Their goal is to find effective therapies for challenging medical conditions, particularly through partnerships and grants, such as those from the National Institutes of Health.

Boston, MassachusettsHeadquarters
2018Year Founded
$25.9MTotal Funding
GRANTCompany Stage
AI & Machine Learning, BiotechnologyIndustries
11-50Employees

Benefits

Extremely generous equity package
Competitive salary
Healthcare benefits
Generous vacation and parental leave
Super cool team building activities
Flexible work schedule

Risks

Increased competition from new AI entrants may erode market share.
Reliance on tech partnerships poses risks if strategic misalignments occur.
High R&D costs for 'undruggable' targets may impact financial sustainability.

Differentiation

1910 Genetics integrates AI, computation, and biological automation for drug discovery.
Their AI model, CANDID-CNS(TM), outperforms industry standards in blood-brain barrier prediction.
They focus on transforming 'undruggable' targets into treatable conditions.

Upsides

Accenture's investment enhances 1910 Genetics' AI platform and accelerates drug development.
Partnership with Microsoft leverages high-performance computing for drug discovery.
Strategic leadership appointments strengthen their position in AI-driven biotechnology.

Land your dream remote job 3x faster with AI